When asked about the importance of social security, Senior Vice President of the insurance company Nationwide Financial Services, David L. Giertz, highlighted in an interview with the Wall Street Journal at http://www.wsj.com/video/speak-to-your-clients-about-social-security/8B2F5FA4-B0E8-4D71-A1E3-D29AA2711CC5.html about having a comprehensive, well-crafted retirement plan. With regard to this, he mentioned how financial advisors are often hesitant about discussing social security with their clients, which serves as a problem when it comes to making the most out of social security. In his interview, David Giertz discussed a research that he conducted based on the importance of social security to retirees and employed people ten years away from retirement, and found that the majority of clients considered changing their financial advisors if the advisors refrained from discussing social security with them, which only emphasizes the value of social security to clients.
David Giertz currently holds the post of a financial advisor for Nationwide Investment Services, working from Columbus, Ohio. Working in the field of finance, he has amassed more than 30 years worth of experience and has achieved success in four exams, thus securing registration with the FINRA of a Broker. David Giertz’ job entails being a part of the sales and financial distribution personnel with various brokerage firms and conducting businesses in investment products and services like stocks, bonds, and security transactions.
Giertz has previously worked as the Vice President of sales for FI/WH from 2009 to 2013 and is currently serving as the Vice President of Distribution and Sales at Nationwide Financial since 2013 on Facebook. His vast experience at such high posts enabled him to look at the downside of using social security too early, and thus carried out studies to prove the optimal time for when social security should be availed, keeping considerations like health and taxation in mind, and looking at how they influence the entire retirement experience on Finra.org.
A Quick Laydown Of The Brazilian Court System
The Brazilian judiciary or courts are independent of the other branches of government just like in the United States. This means that the decisions of the courts are not affected by the legislative or executive branch of Brazil in their rulings and proceedings. Congress and the President do not involve themselves or impact the rulings of the courts in Brazil.
Starting from the bottom, Brazilian courts have a first instance court which is the lowest court level. They are local courts. Then, there are second instance courts, which are regional. They can override first instance courts. Above the second instance courts are the superior courts. These courts can overrule the second and first instance courts. At the very top of Brazil’s judiciary is the supreme federal court. This is the highest court in Brazil and its ruling are final and binding.
Brazilian Attorney, Ricardo Tosto
Ricardo Tosto is a Brazilian attorney who practices corporate litigation, compliance and legal counsel in Brazil. Mr. Tosto is one of the founders and is currently a partner at Leite, Tosto and Barros Attorney Associates. Ricardo Tosto completed his law degree at Mackenzie Presbyterian University.
Today, Ricardo Tosto is considered to be among the top corporate lawyers in Brazil. He has successfully defended major companies and litigated others in cases that have now set precedents for other rulings. Ricardo Tosto’s defense in these major corporate and business cases have also become an example for other lawyers to follow. Mr. Tosto’s legal cases and defenses have also led to the formation of new economic laws designed to promote business and crack down on fraudulent practices. Ricardo Tosto himself is a big promoter of ethics and a good, clean fight in the court room.
https://www.facebook.com/people/Ricardo-Tosto/100010033200857 for more.
Mikhail Blagosklonny studies cancer and aging. Studies within cancer and aging are some of the most complex studies. Blagosklonny earned his M.D. in internal medicine. He also received a PhD in experimental medicine and cardiology.
He received a highly honorable position as associate professor of medicine at New York Medical College. This is a platform for him to share his knowledge. He later left the platform to be senior scientist at Ordway Research Institute. When we look at some of Mikhail Blagosklonny’s methods up close we find he researches targeted cancer therapies which extend people’s lives as they only cause damage to the cancer infected cells.
He also studies biogerontology and anti-aging drugs and discovers their underlying mechanisms. According to Impact Journals, Mikhail Blagosklonny made a hypothesis about TOR signaling and linked it to playing a role in aging and cancer. The drug rapamycin is recommended to treat what is found in that particular hypothesis. It is a hypothesized treatment for life extension.
Mikhail Blagosklonny doesn’t limit himself to studying cancer but also is an editor in chief of “Aging” an open access medical journal. “Cell Cycle” is a scientific journal he also applies his editor in chief duties to and also “Oncotarget” another medical journal that covers oncology.
Blagosklonny doesn’t stop there as his work ethic shows in his credentials of publishing over 270 papers in journals his peers see.
By now it should be easy for you to see the type of man Mikhail Blagosklonny is. A over achieving and kindhearted person, A person who dedicated his life to studying just to give back. Mikhail Blagosklonny is an example for everyone.